Diagnos Laboratorium Utama Tbk. vs Royaltama Mulia Kontraktorindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.4K 24h volume), while Royaltama Mulia Kontraktorindo Tbk. trades at Rp338 (market cap 434.17B, 3.94M 24h volume). The key difference: Royaltama Mulia Kontraktorindo Tbk. is the larger of the two by market cap, and Royaltama Mulia Kontraktorindo Tbk. is more actively traded (3.94M versus 24.4K). Which is the better fit depends on your goals.
| DGNS | RMKO | |
|---|---|---|
Market Cap | 308B | 434.17B |
Volume | 24.4K | 3.94M |
Lot | 244 | 39.4K |
Turnover | 5.54M | 1.32B |
Average Price | 227.25 | 335.06 |
Value | 5.54M | 1.32B |
Indicative Equilibrium Price | 230 | 350 |
Indicative Equilibrium Volume | 110 | 1.07K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Royaltama Mulia Kontraktorindo Tbk was established based on Notarial Deed No. 2 datedDecember 18, 2017 of Muhammad Firmansyah, S.H., M.Kn., a public notary in Tangerang. The Company started its commercial operations in 2018.
Read more on RMKO →